Drugs Manufactured With A Forged License, FIR Lodged, Drugs Worth 23.93 Lakhs Seized

Hyderabad: Drugs Control Administration, Telangana, has detected a significant case of fraudulent activity within the pharmaceutical industry. An investigation conducted by DCA officials has revealed that Ovoid Pharmachem Pvt. Ltd., located at Plot No. 318, Subashnagar, Quthbullapur Mandal, Medchal-Malkajgiri District, engaged in the forgery of a drug manufacturing license.

VB Kamalasan Reddy (IPS), Director General, DCA Telangana said in a press release that “Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., was involved in the creation of a forged Drug Manufacturing license in Form-25, bearing No. TS/MFG2019-43319, L.Dis.No: 315995/TS/2022 dated: 05/07/2022, for certain drug products which were not authorized for the company by the Drugs Control Administration, Telangana. This unlawful activity was carried out with the intention to deceive drug regulatory authorities, pharmaceutical manufacturers, distributors, and the public.

Upon verification of the Drugs Control Administration, Telangana licensing database on the ODLS (Online Drug Licensing System) Portal, it has been confirmed that Ovoid Pharmachem Pvt. Ltd. created a fake drug licence for certain drug products.

DCA also detected that the firm manufactured and sold certain drug products under this fraudulent license. Drugs Control Administration officials seized stocks worth Rs. 23.93 lakhs, including 800 Kgs of Activated Charcoal 250 mg and Simethicone 80 mg Pellets.”

Drugs Control Administration, Telangana, has filed a complaint with the Jeedimetla Police Station. FIR No. 327/2024 has been registered on 05-04-2024 against Mr. Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., under Sections 420 (Cheating) and 468 (Forgery) of the Indian Penal Code (IPC).

It is imperative to emphasize that the manufacturing and sale of pharmaceutical products under forged licenses pose a significant threat to public health and safety. All manufacturers shall comply strictly with regulatory requirements and maintain the highest standards of ethical conduct.

Related Posts

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Shimla: The National Green Tribunal (NGT) has issued notice to a pharmaceutical manufacturing unit in Himachal Pradesh over allegations of environmental norm violations, including noise pollution, discharge of untreated or…

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Lucknow:  As Uttar Pradesh intensifies efforts to achieve its ambitious $1 trillion economy target, the Yogi Adityanath government is steadily expanding its focus beyond traditional manufacturing and services by aggressively…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Haryana Launches ‘Make in Haryana Industrial Policy’

Haryana Launches ‘Make in Haryana Industrial Policy’